Zobrazeno 1 - 10 of 96 pro vyhledávání: '"R. Heithecker"'
1
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles
Autor: Jean-Pierre Desager, C. Buicu, Ulysse Gaspard, Christoph Gerlinger, R. Heithecker, Jan Endrikat
Publikováno v: Contraception. 69:271-278
In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 jig ethinylestradiol and 3 mg drospirenone (EE + DRSP = Yasmin(TM)), with a reference preparation containing 30 jig ethinylestradiol and 150 jig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a8a8b3073cec1fd64e616b5ac22a28
https://doi.org/10.1016/j.contraception.2003.11.003
Zobrazit plný text záznamu
2
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism
Autor: Ulysse Gaspard, Crina Buicu, André Scheen, R. Heithecker, Pierre Lefebvre, Christoph Gerlinger, Jan Endrikat
Publikováno v: Contraception. 67:423-429
In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (Yasmin) with a reference preparation containing 30 microg ethinylestradiol and 150 microg desogest
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e627b7bd775f9b145e5616abaae631f5
https://doi.org/10.1016/s0010-7824(02)00537-1
Zobrazit plný text záznamu
3
Use of an oral contraceptive containing drospirenone in an extended regimen
Autor: M. Sillem, R. Schneidereit, A. O. Mueck, R. Heithecker
Publikováno v: The European Journal of Contraception & Reproductive Health Care. 8:162-169
As well as providing reliable contraception, modern low-dose oral contraceptives may offer some non-contraceptive advantages. Positive effects on problems such as edema with weight increase and breast tenderness, bloating, dysmenorrhea, and an improv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f774617174196847708dbcf42b24329
https://doi.org/10.1080/ejc.8.3.162.169
Zobrazit plný text záznamu
4
Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 μg of ethinyl estradiol on the human endometrium
Autor: Elisabeth Johannisson, Frans M. Helmerhorst, Jean-Michel Foidart, R. Heithecker, Aldo Campana, Frank Lüdicke
Publikováno v: Fertility and Sterility. 76:102-107
Objective: To provide an in-depth assessment of the effects of the combined oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone (Yasmin, Schering AG, Berlin) on the endometrium by means of endometrial morphometry in com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42455b4b12197e31a2a020dfbb016edd
https://doi.org/10.1016/s0015-0282(01)01834-9
Zobrazit plný text záznamu
6
Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol
Autor: A Wolf, K Thomas, W Schmidt, M Grillo, F Freundl, P Rosenbaum, W Rossmanith, F M Helmerhorst, Wolfgang Wuttke, R. Heithecker
Publikováno v: The European Journal of Contraception & Reproductive Health Care. 5:16-24
To investigate ovulation inhibition with drospirenone, a novel progestogen that has a profile similar to natural progesterone, when given alone or in combination with ethinylestradiol.Hormonal parameters (LH, FSH, 17beta-estradiol and progesterone) a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf540ee7e44b985df7d40085fa2236d5
https://doi.org/10.1080/13625180008500376
Zobrazit plný text záznamu
7
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel
Autor: G. M. Bouw, R. Heithecker, W. Wuttke, Jean-Michel Foidart, Christoph Gerlinger
Publikováno v: Scopus-Elsevier
To assess the contraceptive reliability, cycle control and tolerance of a new monophasic oral contraceptive (Yasmin) containing 30 microg ethinylestradiol and 3 mg drospirenone and compare it with a preparation containing an equal dose of ethinylestr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de84519f0457292b9ebfe5d59d9a813
https://doi.org/10.1080/13625180008500387
Zobrazit plný text záznamu
8
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism
Autor: R. Heithecker, Jean-Michel Foidart, A. Welter, Wolfgang Oelkers, N. Dombrovicz
Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 80:1816-1821
Combined hormonal oral contraceptives (OCs) may lead to a mild rise in blood pressure and body weight. In rare instances, large increments in blood pressure are measured. We investigated the effect of a combination of ethinyl estradiol (EE) plus a pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d2b70ce83e0c7acbd1707da98ef44b
https://doi.org/10.1210/jcem.80.6.7775629
Zobrazit plný text záznamu
9
Plasma Estriol Levels after Intramuscular Injection of Estriol and Two of Its Esters1
Autor: R. Heithecker, S.Z. Cekan, Aedo Ar, B.-M. Landgren
Publikováno v: Hormone Research. 35:234-238
Twelve female volunteers from Berlin and 9 from Stockholm, all using a contraceptive pill (30 µg ethinyl estradiol and 150 µg levonorgestrel), received an intramuscular injection of estriol (E3
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7b5490bd932ef73da1ece50803b47fa
https://doi.org/10.1159/000181911
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje